Medicare Enrolled
Dr. Ralph Gousse, M. D.
Hematology · Altamonte Springs, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gousse from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gousse? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gousse
Dr. Ralph Gousse is a hematology in Altamonte Springs, FL, with 19 years in practice. Based on federal Medicare data, Dr. Gousse performed 183,759 Medicare services across 4,782 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gousse received a total of $7,813 from 62 pharmaceutical and/or device companies across 411 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gousse is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 25% volume in FL$ $7,813 industry payments
Medicare Practice Summary
Medicare Utilization ↗183,759
Medicare services
Top 25% in FL for hematology
4,782
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~9,672 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 66,300 | $0 | $4 |
| Iron infusion (Injectafer) | 30,750 | $1 | $3 |
| Iron sucrose injection (Venofer) | 24,100 | $0 | $5 |
| Epoetin alfa injection (Procrit) for anemia | 18,630 | $6 | $23 |
| Denosumab injection (Prolia/Xgeva) | 12,240 | $18 | $51 |
| Immune globulin infusion (Gammagard) | 8,330 | $36 | $108 |
| Blood draw (venipuncture) | 3,627 | $8 | $9 |
| Complete blood count (CBC) with differential | 3,360 | $8 | $29 |
| Injection, eflapegrastim-xnst, 0.1 mg | 3,036 | $26 | $116 |
| Dexamethasone injection (steroid) | 2,700 | $0 | $3 |
| Iron infusion (Monoferric) | 1,800 | $17 | $57 |
| Drug injection, under skin or into muscle | 1,405 | $10 | $69 |
| Office visit, established patient (20-29 min) | 1,250 | $64 | $239 |
| Anti-nausea injection (Aloxi/palonosetron) | 710 | $1 | $28 |
| Office visit, established patient (30-39 min) | 704 | $96 | $339 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 539 | $1 | $6 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 521 | $46 | $189 |
| Injection of additional new drug or substance into vein | 508 | $11 | $61 |
| Anti-nausea injection (ondansetron/Zofran) | 416 | $0 | $9 |
| Administration of chemotherapy into vein, 1 hour or less | 359 | $97 | $378 |
| Injection, zoledronic acid, 1 mg | 291 | $6 | $69 |
| Injection, diphenhydramine hcl, up to 50 mg | 250 | $1 | $3 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 234 | $15 | $56 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 212 | $21 | $84 |
| Prothrombin time test (blood clotting) | 145 | $4 | $15 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 133 | $3 | $11 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 120 | $55 | $206 |
| Red blood count automated, with additional calculations | 101 | $5 | $20 |
| Hospital follow-up visit, high complexity | 92 | $94 | $285 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 91 | $24 | $89 |
| New patient office visit (30-44 min) | 89 | $74 | $298 |
| New patient office visit (45-59 min) | 79 | $124 | $453 |
| Administration of chemotherapy into vein, each additional hour | 78 | $21 | $79 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 78 | $16 | $59 |
| Injection of drug or substance into vein | 76 | $27 | $156 |
| Administration of additional new drug or substance into vein, 1 hour or less | 58 | $49 | $178 |
| Initial hospital admission, high complexity | 58 | $137 | $556 |
| Infusion, normal saline solution , 1000 cc | 51 | $2 | $7 |
| Office visit, established patient, complex (40-54 min) | 49 | $136 | $474 |
| Automated urinalysis | 46 | $2 | $8 |
| Drawing of blood for a medical problem | 42 | $70 | $277 |
| Infusion into a vein for hydration, each additional hour | 39 | $10 | $42 |
| Infusion into a vein for hydration, 31-60 minutes | 24 | $25 | $156 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 21 | $129 | $467 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 17 | $1 | $7 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
58.9% high complexity
35.8% medium
5.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,813
Total received (2018-2024)
Avg $1,116/year across 7 years
Top 48% in FL for hematology
62
Companies
411
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,620 (97.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$194 (2.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,970
2023$1,963
2022$1,365
2021$474
2020$362
2019$932
2018$748
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$695
Celgene Corporation
$664
Novartis Pharmaceuticals Corporation
$638
E.R. Squibb & Sons, L.L.C.
$564
PFIZER INC.
$521
Genentech USA, Inc.
$426
Gilead Sciences, Inc.
$374
Astellas Pharma US Inc
$230
AstraZeneca Pharmaceuticals LP
$211
Amgen Inc.
$210
Apellis Pharmaceuticals, Inc.
$205
Pharmacyclics LLC, An AbbVie Company
$195
Kite Pharma, Inc.
$175
Incyte Corporation
$170
Karyopharm Therapeutics Inc.
$166
Seagen Inc.
$166
Exelixis Inc.
$161
Merck Sharp & Dohme LLC
$152
JAZZ PHARMACEUTICALS INC.
$140
TESARO, Inc.
$124
Daiichi Sankyo Inc.
$98
Merck Sharp & Dohme Corporation
$96
Coherus Biosciences Inc.
$95
Rigel Pharmaceuticals, Inc.
$92
BeiGene USA, Inc.
$85
EMD Serono, Inc.
$84
GlaxoSmithKline, LLC.
$75
EISAI INC.
$69
G1 Therapeutics, Inc.
$56
TerSera Therapeutics LLC
$55
SOBI, INC
$53
Eisai Inc.
$52
Global Blood Therapeutics, Inc.
$47
PharmaEssentia USA Corporation
$46
Mirati Therapeutics, Inc.
$45
Blueprint Medicines Corporation
$40
ADC Therapeutics America, Inc.
$37
GENZYME CORPORATION
$37
ABBVIE INC.
$37
ARRAY BIOPHARMA INC
$36
INSYS Therapeutics Inc
$35
Sun Pharmaceutical Industries Inc.
$28
Aurobindo Pharma USA, Inc.
$26
Foundation Medicine, Inc.
$24
Dendreon Pharmaceuticals LLC
$23
Pharmacyclics LLC, an AbbVie Company
$23
Taiho Oncology, Inc.
$20
Sysmex Inostics Inc
$19
Pharmacosmos Therapeutics Inc.
$18
TG THERAPEUTICS, INC.
$18
CTI BioPharma Corp.
$17
MorphoSys, US Inc.
$16
Janssen Pharmaceuticals, Inc
$15
CSL Behring
$15
Verastem, Inc.
$14
SERVIER PHARMACEUTICALS LLC
$14
Stemline Therapeutics Inc.
$14
Alexion Pharmaceuticals, Inc.
$14
MEDIVATION FIELD SOLUTIONS LLC
$13
Kyowa Kirin, Inc.
$12
Acrotech Biopharma LLC
$12
Veracyte, Inc.
$1
Top 3 companies account for 25.6% of total payments
Associated products mentioned in payments ›
ADCETRIS · AUGTYRO · AYVAKIT · Alecensa · Avastin · BAVENCIO · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRUKINSA · CABOMETYX · CERDELGA · COSELA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · ELIQUIS · ELITEK · ENHERTU · ERLEADA · Empaveli · Enhertu · Erivedge · Erleada · FOUNDATIONONE · Fabhalta · Folotyn · GAZYVA · IBRANCE · IMBRUVICA · INLYTA · INQOVI · Idelvion · Imbruvica · Inrebic · JAKAFI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MVASI · Marqibo · Nplate · OJJAARA · OPDIVO · OPDUALAG · OXBRYTA · Orserdu · PADCEV · PEMAZYRE · PIQRAY · POTELIGEO · PROMACTA · PROVENGE · Padcev · Perjeta · Pomalyst · REBLOZYL · RYBREVANT · Rezlidhia · SANDOSTATIN · SCEMBLIX · SOLIRIS · SYNDROS · TASIGNA · TECENTRIQ · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trodelvy · UKONIQ · Udenyca · VENCLEXTA · VONJO · Vanflyta · Venclexta · Vonjo · XALKORI · XARELTO · XPOVIO · XTANDI · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $4 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
17
Per 100K population
3.6
County median income
$83,030
Nearest hospital
ASPIRE HEALTH PARTNERS
7.4 mi
7.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Gousse is a mixed practice specialist, with above-average Medicare volume (top 25% in FL), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Gousse experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Gousse performed 66,300 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gousse receive payments from pharmaceutical companies?
Yes. Dr. Gousse received a total of $7,813 from 62 companies across 411 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gousse's costs compare to other hematologys in Altamonte Springs?
Dr. Gousse's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gousse) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in Altamonte Springs
Browse hematologys in Altamonte Springs ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology